Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.
J Invest Dermatol
; 135(4): 1199-1202, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25431852
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glycoproteins
/
Antigens, CD
/
Sezary Syndrome
/
Antibodies, Monoclonal, Humanized
/
Membrane Proteins
/
Mutation
/
Antigens, Neoplasm
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
J Invest Dermatol
Year:
2015
Document type:
Article